{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T13:23:34Z","timestamp":1785331414136,"version":"3.55.0"},"reference-count":47,"publisher":"Impact Journals, LLC","issue":"16","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,4,18]]},"DOI":"10.18632\/oncotarget.15460","type":"journal-article","created":{"date-parts":[[2017,2,22]],"date-time":"2017-02-22T16:33:37Z","timestamp":1487781217000},"page":"26312-26322","source":"Crossref","is-referenced-by-count":30,"title":["Selenomethionine and methyl selenocysteine: multiple-dose pharmacokinetics in selenium-replete men"],"prefix":"10.18632","volume":"8","author":[{"given":"James R.","family":"Marshall","sequence":"first","affiliation":[{"name":"Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY 14263, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond F.","family":"Burk","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, Vanderbilt University Medical Center, C2104 Medical Center North, Nashville, TN 37232, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rochelle Payne","family":"Ondracek","sequence":"additional","affiliation":[{"name":"Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY 14263, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina E.","family":"Hill","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, Vanderbilt University Medical Center, C2104 Medical Center North, Nashville, TN 37232, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjorie","family":"Perloff","sequence":"additional","affiliation":[{"name":"National Cancer Institute, Bethesda, MD 20892, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warren","family":"Davis","sequence":"additional","affiliation":[{"name":"Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY 14263, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Pili","sequence":"additional","affiliation":[{"name":"Department of Medicine, Indiana University School of Medicine, R3 C516, Indianapolis, IN 46202, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saby","family":"George","sequence":"additional","affiliation":[{"name":"Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY 14263, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Bergan","sequence":"additional","affiliation":[{"name":"Knight Cancer Institute, Oregon Health Sciences University, Portland, OR 97239, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2017,2,17]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0002-8223(00)00189-9","article-title":"Dietary reference intakes for the antioxidant nutrients: vitamin C, vitamin E, selenium, and carotenoids","volume":"100","author":"Monsen","year":"2000","journal-title":"Journal of the American Dietetic Association"},{"key":"2","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1093\/jnci\/90.16.1219","article-title":"Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer","volume":"90","author":"Giovannucci","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"3","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1016\/S0022-5347(05)65500-0","article-title":"Plasma selenium level before diagnosis and the risk of prostate cancer development","volume":"166","author":"Carter","year":"2001","journal-title":"J Urol"},{"key":"4","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1093\/jnci\/92.24.2018","article-title":"Association between alpha-tocopherol, gamma-tocopherol, selenium, and subsequent prostate cancer","volume":"92","author":"Comstock","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"5","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1001\/jama.1996.03540240035027","article-title":"Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group","volume":"276","author":"Park","year":"1996","journal-title":"Jama"},{"key":"6","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1046\/j.1464-410X.2003.04167.x","article-title":"Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial","volume":"91","author":"Clark","year":"2003","journal-title":"BJU international"},{"key":"7","first-page":"630","article-title":"Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer Trial","volume":"11","author":"Clark","year":"2002","journal-title":"Cancer epidemiology, biomarkers & prevention"},{"key":"8","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/jnci\/djg061","article-title":"Selenium supplementation and secondary prevention of nonmelanoma skin cancer in a randomized trial","volume":"95","author":"Clark","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"9","doi-asserted-by":"crossref","first-page":"CRA7004","DOI":"10.1200\/jco.2010.28.18_suppl.cra7004","article-title":"A phase III, intergroup, randomized, double-blind, chemoprevention trial of selenium (Se) supplementation in resected stage I non-small cell lung cancer (NSCLC)","volume":"28","author":"Ruckdeschel","year":"2010","journal-title":"Journal of Clinical Oncology"},{"key":"10","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1001\/jama.2008.864","article-title":"Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)","volume":"301","author":"Crawford","year":"2009","journal-title":"Jama"},{"key":"11","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1158\/1940-6207.CAPR-10-0343","article-title":"Phase III trial of selenium to prevent prostate cancer in men with high-grade prostatic intraepithelial neoplasia: SWOG S9917","volume":"4","author":"Crawford","year":"2011","journal-title":"Cancer prevention research (Philadelphia, Pa)"},{"key":"12","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1039\/b307508g","article-title":"Element selective characterization of stability and reactivity of selenium species in selenized yeast","volume":"19","author":"Tyson","year":"2004","journal-title":"Journal of Analytical Atomic Spectrometry"},{"key":"13","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1158\/1055-9965.EPI-05-0950","article-title":"Effects of chemical form of selenium on plasma biomarkers in a high-dose human supplementation trial","volume":"15","author":"Byrne","year":"2006","journal-title":"Cancer epidemiology, biomarkers & prevention"},{"key":"14","first-page":"djt456","article-title":"Baseline selenium status and effects of selenium and vitamin e supplementation on prostate cancer risk","volume":"106","author":"Klein","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"15","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/j.tiv.2008.08.003","article-title":"Modulation of redox status in human lung cell lines by organoselenocompounds: selenazolidines, selenomethionine, and methylseleninic acid","volume":"22","author":"Moos","year":"2008","journal-title":"Toxicol In Vitro"},{"key":"16","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1079\/PNS2005467","article-title":"Selenium in cancer prevention: a review of the evidence and mechanism of action","volume":"64","author":"Rayman","year":"2005","journal-title":"The Proceedings of the Nutrition Society"},{"key":"17","first-page":"181","article-title":"Anti-tumour promoting activity of diphenylmethyl selenocyanate against two-stage mouse skin carcinogenesis","volume":"6","author":"Bhattacharya","year":"2005","journal-title":"Asian Pac J Cancer Prev"},{"key":"18","doi-asserted-by":"crossref","first-page":"3819s","DOI":"10.1093\/jn\/132.12.3819S","article-title":"Antioxidant regulation of protein kinase C in cancer prevention","volume":"132","author":"Gundimeda","year":"2002","journal-title":"The Journal of nutrition"},{"key":"19","first-page":"7071","article-title":"Redox-mediated effects of selenium on apoptosis and cell cycle in the LNCaP human prostate cancer cell line","volume":"61","author":"Oberley","year":"2001","journal-title":"Cancer Res"},{"key":"20","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1158\/1535-7163.MCT-06-0400","article-title":"Apoptosis induced by selenomethionine and methioninase is superoxide-mediated and p53-dependent in human prostate cancer cells","volume":"5","author":"Zhong","year":"2006","journal-title":"Molecular cancer therapeutics"},{"key":"21","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00280-008-0745-3","article-title":"Sodium selenite induces apoptosis by generation of superoxide via the mitochondrial-dependent pathway in human prostate cancer cells","volume":"63","author":"Zhong","year":"2009","journal-title":"Cancer chemotherapy and pharmacology"},{"key":"22","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1158\/1940-6207.CAPR-14-0042","article-title":"Comparative effects of two different forms of selenium on oxidative stress biomarkers in healthy men: a randomized clinical trial","volume":"7","author":"Goodin","year":"2014","journal-title":"Cancer prevention research (Philadelphia, Pa)"},{"key":"23","first-page":"2882","article-title":"In vitro andstudies of methylseleninic acid: evidence that a monomethylated selenium metabolite is critical for cancer chemoprevention","volume":"60","author":"Ganther","year":"2000","journal-title":"Cancer Res"},{"key":"24","first-page":"52","article-title":"Delineation of the molecular basis for selenium-induced growth arrest in human prostate cancer cells by oligonucleotide array","volume":"63","author":"Ip","year":"2003","journal-title":"Cancer Res"},{"key":"25","first-page":"R556","article-title":"Human selenite metabolism: a kinetic model","volume":"257","author":"Zech","year":"1989","journal-title":"The American journal of physiology"},{"key":"26","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1093\/ajcn\/54.5.917","article-title":"Human [74Se]selenomethionine metabolism: a kinetic model","volume":"54","author":"Zech","year":"1991","journal-title":"The American journal of clinical nutrition"},{"key":"27","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1021\/jf000051f","article-title":"Chemical Speciation Influences Comparative Activity of Selenium-Enriched Garlic and Yeast in Mammary Cancer Prevention","volume":"48","author":"Lisk","year":"2000","journal-title":"Journal of Agricultural and Food Chemistry"},{"key":"28","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1093\/jn\/128.11.1845","article-title":"Lessons from basic research in selenium and cancer prevention","volume":"128","author":"Ip","year":"1998","journal-title":"The Journal of nutrition"},{"key":"29","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1146\/annurev-nutr-071714-034250","article-title":"Regulation of Selenium Metabolism and Transport","volume":"35","author":"Hill","year":"2015","journal-title":"Annual review of nutrition"},{"key":"30","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1158\/1940-6207.CAPR-10-0259","article-title":"Methyl Selenocysteine: single-dose pharmacokinetics in men","volume":"4","author":"Bergan","year":"2011","journal-title":"Cancer prevention research (Philadelphia, Pa)"},{"key":"31","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1158\/1940-6207.CAPR-09-0047","article-title":"Alpha-keto acid metabolites of naturally occurring organoselenium compounds as inhibitors of histone deacetylase in human prostate cancer cells","volume":"2","author":"Pinto","year":"2009","journal-title":"Cancer prevention research (Philadelphia, Pa)"},{"key":"32","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00726-010-0578-3","article-title":"Chemopreventive mechanisms of alpha-keto acid metabolites of naturally occurring organoselenium compounds","volume":"41","author":"Cooper","year":"2011","journal-title":"Amino acids"},{"key":"33","doi-asserted-by":"crossref","first-page":"30950","DOI":"10.1074\/jbc.M114.591461","article-title":"Kynurenine Aminotransferase III, Glutamine Transaminase L Are Identical Enzymes that have Cysteine S-Conjugate \u03b2-Lyase Activity and Can Transaminate l-Selenomethionine","volume":"289","author":"Cooper","year":"2014","journal-title":"Journal of Biological Chemistry"},{"key":"34","doi-asserted-by":"crossref","first-page":"e1476","DOI":"10.1038\/cddis.2014.422","article-title":"HDAC8 and STAT3 repress BMF gene activity in colon cancer cells","volume":"5","author":"Ho","year":"2014","journal-title":"Cell death & disease"},{"key":"35","first-page":"2875","article-title":"Chemoprevention of mammary cancer with Se-allylselenocysteine and other selenoamino acids in the rat","volume":"19","author":"Ganther","year":"1999","journal-title":"Anticancer research"},{"key":"36","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/978-1-4615-1283-7_10","volume-title":"Nutrition and Cancer Prevention: New Insights into the Role of Phytochemicals","author":"Ganther","year":"2001"},{"key":"37","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.taap.2007.09.011","article-title":"Methylation and demethylation of intermediates selenide and methylselenol in the metabolism of selenium","volume":"226","author":"Suzuki","year":"2008","journal-title":"Toxicology and applied pharmacology"},{"key":"38","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1089\/ars.2007.1528","article-title":"From selenium to selenoproteins: synthesis, identity, and their role in human health","volume":"9","author":"Khanna","year":"2007","journal-title":"Antioxidants & redox signaling"},{"key":"39","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1126\/science.1083516","article-title":"Characterization of mammalian selenoproteomes","volume":"300","author":"Gladyshev","year":"2003","journal-title":"Science (New York, NY)"},{"key":"40","doi-asserted-by":"crossref","first-page":"9724","DOI":"10.1016\/S0021-9258(18)81714-8","article-title":"Identification of a selenocysteyl-tRNA(Ser) in mammalian cells that recognizes the nonsense codon UGA","volume":"264","author":"Hatfield","year":"1989","journal-title":"The Journal of biological chemistry"},{"key":"41","first-page":"573","volume-title":"Nutritional Oncology","author":"Heber","year":"2006","edition":"Second"},{"key":"42","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1097\/MCO.0b013e3283139674","article-title":"Selenium and anticarcinogenesis: underlying mechanisms","volume":"11","author":"Combs","year":"2008","journal-title":"Current opinion in clinical nutrition and metabolic care"},{"key":"43","unstructured":"McCormick. Range Findings and Acute Oral Toxicity Studies of Chemopreventive Agents. Final Report for N01-CN-05130. 2002."},{"key":"44","unstructured":"McCormick. Fourteen-day oral range finding studies and twenty-eight day oral toxicity studies in dogs: Selenomethyl-selenocysteine. Final Report for N01-CN-15140. 2003."},{"key":"45","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1207\/S15327914NC401_5","article-title":"Se-methylselenocysteine: a new compound for chemoprevention of breast cancer","volume":"40","author":"Ip","year":"2001","journal-title":"Nutrition and cancer"},{"key":"46","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1158\/1055-9965.EPI-13-1308","article-title":"A Prospective Study of Plasma Selenoprotein P, Lung Cancer Risk Among Low-Income Adults","volume":"23","author":"Blot","year":"2014","journal-title":"Cancer epidemiology, biomarkers & prevention"},{"key":"47","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the Eastern Cooperative Oncology Group","volume":"5","author":"Carbone","year":"1982","journal-title":"American journal of clinical oncology"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.15460","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,24]],"date-time":"2022-07-24T15:56:30Z","timestamp":1658678190000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.15460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,17]]},"references-count":47,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2017,4,18]]}},"alternative-id":["15460","28412747"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.15460","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,17]]}}}